Skip to content
healthcare.dev

Poly Hist Forte

NDC 50991-626, Doxylamine Succinate and Phenylephrine Hydrochloride, tablet, from Poly Pharmaceuticals, Inc..

Product NDC
50991-626
Status
Listed
Labeler
Poly Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50991-626 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXYLAMINE SUCCINATE10.5 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
50991-626-0150991062601100 TABLET in 1 BOTTLE (50991-626-01)
50991-626-025099106260212 BLISTER PACK in 1 CARTON (50991-626-02) / 1 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 50991062601

    GET /v1/drugs/nadac/50991062601

Use it

Look up 50991-626 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50991-626 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50991-626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.